Click here for NJ Preventive Cardiology practice brochure

Our mission:

For over a decade now, Dr. R. deGoma and New Jersey Preventive Cardiology and Cholesterol Clinic remain committed to providing our patients with world-class heart attack and stroke preventive care using the latest technologies and personalized evidence-based therapies aimed to stop the disease on its track, induce plaque regression and disease reversal to prevent most heart attacks and strokes while reducing escalating healthcare cost. We are also committed to mentoring and supporting our primary care physicians.

See how plaques cause heart attack and stroke and how evidence-based preventive medical therapy stops disease progression and prevents plaque rupture. Click this link to view:

http://www.youtube.com/watch?v=fTj9dEqA1k4

What happens to the patients in the cardiology practice where 85% of high risk patients are treated to the recommended LDL cholesterol goal of less than 100 mg/dl; and where there are more patients with LDL cholesterol less than 50 mg/dl than over 130 mg/dl?

Patient outcomes markedly improved; cardiovascular events nearly come to a halt and healthcare cost is reduced.

---

While physicians need to address all modifiable risk factors and use evidence-based therapies to treat high risk patients to recommended goals, optimal cholesterol therapy is the cornerstone of heart attack and stroke prevention. No other single therapy can match the large volume of scientific data from placebo-controlled clinical trials demonstrating both its safety and efficacy in altering the usual progressive course of atherosclerosis. Analysis of the STENO-2 showed that cholesterol therapy accounted for more than 70% of the cardiovascular risk reduction.

---

While treatment of any risk factors can slow down plaque progression, only aggressive cholesterol treatment has been shown to reliably induce plaque regression. The above slide demonstrates the potency of advanced cholesterol therapy in inducing plaque regression after just three years of treatment.

 

---

 

 

Jim has several cardiovascular risk factors that put him in a high risk category - meaning that in the next 10 years, he is more likely to have a heart attack, stroke, sudden cardiac death, need cardiac hospitalizations and procedures - stent, heart bypass, etc. He is the group of patients that have the highest consumption of expensive cardiovascular healthcare resources.

Jim can downgrade his risk status by evidence-based optimal medical preventive therapy. Aggressive cholesterol treatment as a central component of optimal medical therapy causes plaque stabilization and induces plaque regression. Reduced event rate = lower healthcare cost = lower premium in 2014.

To view our published performance data, please click here.